Login
$DNTH
$89.20 -$0.35 (0.39%) After hours

Ownership

13F as of Q2 2026 · 57.3M shares outstanding

Who owns DNTH?

By type of holder
Institutions 100.0% Insiders 0.0% Everyone else 0.0%
Concentration Top 10 holders own 58.0%
FMR LLC 14.3% · Avidity Partners Management LP 3.7%
Institutional ownership
100.0%
0 pts vs last qtr
Institutional holders
267
+26 vs last qtr
Net shares bought
+1.4M
by institutions in Q2 2026
New / sold out
64 / 38
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • T. Rowe Price Investment Management, Inc. +2.6M
  • Price T Rowe Associates Inc /MD/ +1.4M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Ra Capital Management, L.P. SOLD OUT −2.6M
  • Avidity Partners Management LP −2.1M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$40.1M
12 notices from 6 people
Shares covered
479.6K
0.84% of the company
Arranged in advance
100%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$14.3M$28.6MDec 2025: $879.4K under a 10b5-1 planDecJanFebMar 2026: $28.6M under a 10b5-1 planMarApr 2026: $719.4K under a 10b5-1 planAprMayJun 2026: $4.8M under a 10b5-1 planJunJul 2026: $3.1M under a 10b5-1 planJulAugSep 2026: $2.0M under a 10b5-1 planSepOctNov
Largest proposed sellers
  • Ryan Savitz Officer 10b5-1 $13.7M
  • Marino Garcia Director 10b5-1 $10.6M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2022–FY2025
+4317.3%
+253.50% a year
Each share's claim on the business
−97.7%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $40.1M
over 4 fiscal years
Diluted shares, split-adjusted
848.0K19.9M39.0M2022: 874.2K shares'222023: 5.2M shares'232024: 33.3M shares'242025: 38.6M shares'25
Buybacks Stock-based comp
$0$11.4M$22.8M2022 buybacks: $02022 stock comp: $1.5M'222023 buybacks: $02023 stock comp: $2.9M'232024 buybacks: $02024 stock comp: $12.9M'242025 buybacks: $02025 stock comp: $22.8M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years67% Under 1 year33%
Quarterly turnover
20.3%
of institutional shares changed hands
Top 10 managers, median time held
2.8 years

Super Investors

Investment managers reporting DNTH on Form 13F
F
FMR LLC
Shares
8.2M
% of company
14.30%
Change vs last qtr
+432.2K (+5.6%)
Held since
2023
AP
Avidity Partners Management LP
13D · 4.9%
Shares
2.1M
% of company
3.67%
Change vs last qtr
−2.1M (−50.0%)
Held since
2023

28 more super investors behind a free account

See every manager holding Dianthus Therapeutics, Inc. /DE/, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting DNTH on Form N-PORT; together they hold 46.2% of the company
FG
Fidelity Mt. Vernon Street Trust
Position value
$168M
% of company
2.78%
% of the fund
0.17%
As of
August 31, 2026
VT
Position value
$161M
% of company
2.88%
% of the fund
0.01%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Dianthus Therapeutics, Inc. /DE/ and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
TK
Tomas Kiselak
5%+ holder13D · 4.9%
Shares
2.1M
% of company
3.73%
Change vs last qtr
—
Held since
—
PE
Peter Evan Harwin
5%+ holder13D · 4.9%
Shares
2.1M
% of company
3.73%
Change vs last qtr
—
Held since
—

5 more holders behind a free account

See every insider and 5%+ holder of Dianthus Therapeutics, Inc. /DE/.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support